 Since 9 August 2009 Hemofarm has been a member of the German STADA Group.In August 2016, Hemofarm bought the assets of a Serbian minor pharmaceutical company "Ivančić i sinovi" for undisclosed amount.Hemofarm’s R&D division was established in 1990, and it has been recognized by STADA as a competence center for development of new generic products not only for local and regional markets, but also for the whole STADA Group.